Organigram is one of the few companies to have distribution of their recreational cannabis in all 10 provinces
Organigram Holdings Inc. is the parent company of Organigram Inc., a leading Canadian licensed producer of premium quality cannabis and extract-based products.
“Where the majority of companies went with large green house expansions, our facility is three levels. We actually do vertical cultivation”, says CEO, Greg Engel.
Organigram’s production facility is located on a 14-acre campus in Moncton, New Brunswick. There, its Phase 4 fully-funded expansion project is underway to increase target production capacity to 113,000 kg/year. Not to mention, they expect construction is to be completed by the end of 2019.
Furthermore, the Phase 4 expansion includes a state-of-the-art mechanical system. Additionally, it has an improved irrigation system which they expect to be one of the most sophisticated in North America.
More on Organigram Holdings
Organigram began as a medical cannabis provider. Today, the company is focusing on producing high-quality, indoor-grown cannabis for patients and adult recreational consumers in Canada. They’re also developing international business partnerships to extend the its global footprint.
“We’ve had four quarters in a row now, positive adjusted EBITDA. And I think that’s a big differentiator for us”, say Engel.
Organigram is focusing on translating operational excellence into strong financial results and return on investment for shareholders.
For more information on Organigram Holdings Inc. (OGI:TSX, OGI:NASDAQ) please fill out the form below.